Related Experiment Video
Updated: Nov 27, 2025

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
Published on: August 18, 2023
Cardiology Involvement in Patients with Breast Cancer Treated with Trastuzumab
Biniyam G Demissei1, Srinath Adusumalli1, Rebecca A Hubbard2
1Department of Medicine, Division of Cardiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.
Insights
Cardiology involvement in breast cancer patients receiving trastuzumab improves cardiovascular monitoring and risk factor management. This collaboration enhances adherence to guidelines and positively impacts blood pressure and BMI.
Area of Science:
- Cardio-oncology
- Breast Cancer Treatment
- Cardiovascular Monitoring
Background:
- Limited evidence exists on cardiology's role in cancer patient care.
- Trastuzumab therapy for breast cancer can pose cardiovascular risks.
Purpose of the Study:
- To assess cardiology involvement's impact on cardiovascular monitoring adherence.
- To evaluate its effect on risk factor management in breast cancer patients on trastuzumab.
Main Methods:
- Retrospective cohort study of 1,047 breast cancer patients treated with trastuzumab.
- Defined cardiology involvement as a visit within 3 months prior to therapy initiation.
- Compared guideline-adherent monitoring (echocardiography) and risk factors (BP, BMI) between groups.
Main Results:
- 28% of patients had cardiology involvement.
- Cardiology involvement was linked to higher guideline-adherent monitoring (76.4% vs. 60.1%).
- Associated with lower systolic blood pressure and reduced BMI in overweight patients.
Conclusions:
- Cardiology involvement enhances cardiovascular monitoring adherence in breast cancer patients on trastuzumab.
- It is associated with modest improvements in blood pressure and BMI control.
- Highlights the benefit of integrated cardio-oncology care.
Background:
There is limited evidence regarding the impact of cardiology involvement in the care of cancer patients.
Objectives:
We evaluated the impact of cardiology involvement on guideline-adherent cardiovascular monitoring and risk factor management in breast cancer patients treated with trastuzumab.
Methods:
In a single-center retrospective cohort study, we evaluated electronic health records from 1,047 breast cancer patients receiving trastuzumab between January 2009 and July 2018. A visit to a cardiology provider beginning from the 3 months prior to cancer therapy initiation until the last contact date defined cardiology involvement. Guideline-adherent monitoring, defined by echocardiography assessment within the 4 months prior to trastuzumab initiation and follow-up echocardiography at least every 4 months during therapy, was compared in patients with and without cardiology involvement prior to treatment initiation. Multivariable associations between cardiology involvement and time-varying risk factors blood pressure (BP) and body mass index (BMI) were assessed using generalized estimating equations.
Results:
Cardiology involvement occurred in 293 (28%) patients. A higher proportion of patients with cardiology involvement prior to trastuzumab initiation had guideline-adherent monitoring (76.4% versus 60.1%, p=0.007). Cardiology involvement was associated with an average 1.5mmHg (95% CI -2.9,-0.1, p=0.035) lower systolic BP; which was more pronounced in those with hypertension (-2.7mmHg (95% CI -4.6,-0.7, p=0.007)). Cardiology involvement was associated with a lower BMI in patients with baseline BMI≥25 kg/m2 (mean difference; -0.5 (95% CI -1.0,-0.1, p=0.027)).
Conclusions:
Cardiology involvement in breast cancer patients treated with trastuzumab is associated with greater adherence to cardiovascular monitoring and modest improvements in risk factor control.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Imaging Studies for Cardiovascular System V: CT
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care